Outcomes after successful endovascular t
herapy in acute isc
hemic stroke are associated wit
h onset-to-reperfusion time (ORT) and t
he National Institutes of Healt
h Stroke Scale (NIHSS) score. In intravenous recombinant tissue plasminogen activator t
herapy, t
he NIHSS&ndas
h;time score, calculated by multiplying onset-to-treatment time wit
h t
he NIHSS score,
has been s
hown to predict clinical outcomes. In t
his study, we assessed w
het
her a similar combination of t
he ORT and t
he NIHSS score can be applied to predict t
he outcomes after endovascular t
herapy.<
h4 id="absSec_2">Met
hods
h4>
We retrospectively reviewed the charts of 128 consecutive ischemic stroke patients with successful reperfusion after endovascular therapy. We analyzed the association of the ORT, the NIHSS score, and the NIHSS–time score with good outcome (modified Rankin Scale score ≤ 2 at 3 months).
<
h4 id="absSec_3">Results
h4>
Good outcome rates for patients with NIHSS–time scores of 84.7 or lower, scores higher than 84.7 up to 127.5 or lower, and scores higher than 127.5 were 72.1%, 44.2%, and 14.3%, respectively (P < .01). Multivariate logistic regression analysis revealed that the NIHSS–time score was an independent predictor of good outcomes (odds ratio, .372; 95% confidence interval, .175-.789) after adjusting for age, sex, internal carotid artery occlusion, plasma glucose level, ORT, and NIHSS score.
<
h4 id="absSec_4">Conclusions
h4>
The NIHSS–time score can predict good clinical outcomes after endovascular treatment.